CD4 and neoplasm: This suggests increased numbers of pro-inflammatory Th1 and Th17 CD4+ T cells which can, in addition to augmenting anti-tumor cytotoxic responses by CD8+ T cells, mediate direct anti-tumor activity by the production of cytokines (34,35).